Transcription factor 21 (TCF21) could promote chicken preadipocytes differentiation at least in part via activating MAPK/JNK pathway.
1. Introduction
In the poultry industry, excessive fat deposition in broiler chicken is not wanted by most customers, because many metabolic diseases like coronary heart disease and arteriosclerosis are strongly related to increased dietary intake of cholesterol
[1]. Increased dietary cholesterol intake from fat may lead to increased serum cholesterol levels and further increased risks of metabolic diseases
[2][3]. Additionally, excessive fat deposition hinders processing and leads to significant reductions in feed efficiency and carcass yield, thus incurring economic losses for poultry producers and processors
[4][5]. In addition, excessive fat deposition in chicken has increased the incidence of metabolic disorders, such as pulmonary hypertension syndrome, sudden death, fatty liver disease
[6][7][8], and reduced reproductive performance, such as less sperm concentration, more sperm with abnormal morphology, and less egg production
[9].
Obesity onset is closely linked with the differentiation of adipocytes
[10][11]. Therefore, to facilitate therapeutic prevention or treatment of obesity, it is of great significance to get a deeper understanding of the molecular mechanisms involved in adipogenesis. Multiple distinct transcription factors and signaling pathways serve together to regulate adipogenesis
[12]. Many studies have provided detailed insights into the role of transcription factors in peroxisome proliferator activated receptor (PPAR) and CCAAT/enhancer binding protein (C/EBP) family, Wnt signaling, and TGF-β signaling in this context
[13][14]. To offer new insights into the molecular mechanisms of adipogenesis, identification of novel transcription factors and pathways regulating adipogenesis is particularly vital. Recently, we have identified a novel transcription factor 21 (TCF21), which promotes chicken preadipocyte differentiation by regulating the expression of lipoprotein lipase (LPL)
[15]. However, the signaling pathways, by which TCF21 influences this differentiation process, remain to be characterized.
2. Overexpression of TCF21 Leads to Enhanced Lipid Droplets Accumulation
To select a suitable time point for the following experiment, we compared the lipid accumulation between LV-control and LV-TCF21 during differentiation. First, we examined the overexpression effect of TCF21 in LV-TCF21 cells and the expression patterns of TCF21 in LV-control and LV-TCF21 cells. The results showed that both mRNA and protein expression levels of TCF21 in LV-TCF21 were significantly higher than those in LV-control before (0 h) and after induction of differentiation (24, 48, 72, 96, 120 h) (
p < 0.01,
Supplementary Figure S1). The expression patterns of TCF21 were similar in LV-control and LV-TCF21 cells that the expressions of TCF21 had an elevated trend after differentiation induction (
Supplementary Figure S1). Specifically, the mRNA and protein expression patterns of TCF21 in LV-control cells were gradually increased after induction (
Supplementary Figure S1). The mRNA expression pattern of TCF21 in LV-TCF21 cells was also gradually increased after induction, but its protein expression in LV-TCF21 cells had a minor decrease at 72 h after induction (
Supplementary Figure S1). Meanwhile, we compared the lipid accumulation between LV-TCF21 and LV-control during differentiation in order to select an appropriate time point for the following experiment. The results showed that LV-TCF21 had remarkably more lipid droplets accumulation since 24 h post-induction of differentiation (
p < 0.05 or
p < 0.01,
Figure S1).
3. MAPK/JNK Signaling Pathway Was Activated by TCF21 Overexpression
Based on these initial findings, we selected 24 h to screen signaling pathways that were significantly activated or repressed in response to TCF21 overexpression. Among the 45 signaling pathways we analyzed, the activity of MAPK/JNK signaling pathway was significantly elevated by TCF21 overexpression (
p = 0.000423,
Figure 1A and
Supplementary Table S2). Western blotting further confirmed that TCF21 overexpression enhanced JNK phosphorylation (
p < 0.01,
Figure 1B,C).
Pathway |
LV-control(mean±SE)
|
LV-TCF21(mean±SE)
|
P-value |
Amino acid deprivation
|
0.41 ± 0.37
|
0.062 ± 0.043
|
0.44
|
Androgen
|
/
|
/
|
/
|
Antioxidant response
|
/
|
/
|
/
|
ATF6
|
0.015 ± 0.0048
|
0.013 ± 0.0027
|
0.72
|
C/EBP
|
/
|
/
|
/
|
cAMP/PKA
|
/
|
/
|
/
|
Cell cycle
|
/
|
/
|
/
|
DNA damage
|
/
|
/
|
/
|
EGR1
|
/
|
/
|
/
|
ER stress
|
0.95 ± 0.72
|
0.90 ± 0.60
|
0.96
|
Estrogen
|
/
|
/
|
/
|
GATA
|
/
|
/
|
/
|
Glucocorticoid
|
/
|
/
|
/
|
Heat shock
|
/
|
/
|
/
|
Heavy metal
|
0.090 ± 0.065
|
0.11 ± 0.078
|
0.87
|
Hedgehog
|
/
|
/
|
/
|
HNF4
|
/
|
/
|
/
|
Hypoxia
|
/
|
/
|
/
|
Interferon regulation
|
/
|
/
|
/
|
Type 1 interferon
|
/
|
/
|
/
|
Interferon-r
|
/
|
/
|
/
|
KLF4
|
/
|
/
|
/
|
Liver X
|
/
|
/
|
/
|
MAPK/Erk
|
0.12 ± 0.043
|
0.11 ± 0.044
|
0.88
|
MAPK/Jnk
|
0.028 ± 0.0060
|
0.19 ± 0.014
|
0.000423
|
MEF2
|
/
|
/
|
/
|
Myc
|
/
|
/
|
/
|
Nanog
|
/
|
/
|
/
|
Notch
|
/
|
/
|
/
|
NFκB
|
0.081 ± 0.037
|
0.20 ± 0.11
|
0.36
|
Oct4
|
/
|
/
|
/
|
Pax6
|
/
|
/
|
/
|
PI3K/Akt
|
/
|
/
|
/
|
PKC/Ca+2
|
/
|
/
|
/
|
PPAR
|
/
|
/
|
/
|
Progesterone
|
/
|
/
|
/
|
Retinoic acid
|
/
|
/
|
/
|
Retinoid X
|
/
|
/
|
/
|
Sox2
|
/
|
/
|
/
|
SP1
|
0.3 ± 0.28
|
0.097 ± 0.067
|
0.52
|
STAT3
|
/
|
/
|
/
|
TGF-β
|
/
|
/
|
/
|
Vitamin D
|
/
|
/
|
/
|
Wnt
|
/
|
/
|
/
|
Xenobiotic
|
/
|
/
|
/
|
Negative control
|
0.00057 ± 0.000067
|
0.000625 ± 0.000062
|
0.59
|
4. MAPK/JNK Signaling and Lipid Droplets Accumulation Are Inhibited by SP600125 in a Dose-Dependent Manner
To investigate the role of MAPK/JNK signaling in chicken adipogenesis, ICP cells were treated with JNK inhibitor SP600125 at the concentrations of 0, 2.5, 5, and 10 μM, respectively. We found that the protein level of p-JNK (
Figure 2A) and accumulation of lipid droplet were reduced by SP600125 in a dose-dependent manner. Additionally, the accumulation of lipid droplets in ICP cells was remarkably decreased by SP600125 at the concentration of 10 μM (
Figure 2B). Therefore, SP600125 at the concentration of 10 μM was used in the following experiment.
5. Inhibition of MAPK/JNK Signaling Attenuates TCF21-Mediated Promotion of Preadipocyte Differentiation
Finally, we performed rescue experiment using LV-control and LV-TCF21 to explore whether MAPK/JNK signaling mediated the impact of TCF21 on preadipocyte differentiation. Although LV-control was derived from ICP, it was not the same as ICP due to lentivirus infection. Therefore, we examined whether SP600125 at the concentration of 10 μM was appropriate to treat LV-control cells in the rescue experiment. We found 10 μM SP600125 was also sufficient to suppress MAPK/JNK signaling and preadipocytes differentiation in LV-control cells (TCF21 (−) SP600125 (−) group vs. TCF21 (−) SP600125 (+) group in
Figure 3). The results of TCF21 (+) SP600125 (−) group compared with TCF21 (−) SP600125 (−) group in
Figure 3 showed that TCF21 promoted preadipocyte differentiation, as evidenced by increased lipid droplets accumulation and expressions of pro-adipogenic genes. The results of TCF21 (+) SP600125 (−) group compared with TCF21 (+) SP600125 (+) group in
Figure 3 showed that inhibition of MAPK/JNK signaling attenuated the promoting effect of overexpression TCF21 on preadipocyte differentiation. The results of TCF21 (−) SP600125 (−) group compared with TCF21 (+) SP600125 (+) group in
Figure 3 showed that the inhibition of MAPK/JNK signaling by SP600125 could not completely neutralize the promoting effect of overexpression TCF21 on preadipocyte differentiation.
This entry is adapted from the peer-reviewed paper 10.3390/genes12121971